Current Drug Targets - Inflammation & Allergy

Continued as Inflammation & Allergy - Drug Targets

Personal Subscription
Volume: 1 Issue: 3, September

Treatment of Allergic Rhinitis: H1-Antihistamines and Intranasal Steroids

Volume:1   Issue: 3
Pp: 215-220
De-Yun Wang
DOI: 10.2174/1568010023344625
Published on: 01 March, 2012

Inflammation and Parkinsons Disease

Volume:1   Issue: 3
Pp: 221-242
Christophe Wersinger and Anita Sidhu
DOI: 10.2174/1568010023344580
Published on: 01 March, 2012

Peroxisome Proliferator-Activated Receptors and the Control of Inflammation

Volume:1   Issue: 3
Pp: 243-248
A. Cabrero, J. C. Laguna and M. Vazquez
DOI: 10.2174/1568010023344616
Published on: 01 March, 2012

Chlamydial Heat Shock Protein 60 and Lipopolysaccharide: Potential Virulence Determinants in Atherogenesis

Volume:1   Issue: 3
Pp: 249-255
Murat V. Kalayoglu
DOI: 10.2174/1568010023344652
Published on: 01 March, 2012

The Mechanisms of Immune-to-Brain Communication in Inflammation as a Drug Target

Volume:1   Issue: 3
Pp: 257-262
Toru Hosoi, Yasunobu Okuma and Yasuyuki Nomura
DOI: 10.2174/1568010023344599
Published on: 01 March, 2012

IL-4 and IL-13: Their Pathological Roles in Allergic Diseases and their Potential in Developing New Therapies

Volume:1   Issue: 3
Pp: 263-269
K. Izuhara, K. Arima and S. Yasunaga
DOI: 10.2174/1568010023344661
Published on: 01 March, 2012

The Use of Leukotriene Modifying Drugs in Asthma and Other Respiratory Diseases

Volume:1   Issue: 3
Pp: 271-275
J. A. Corless and M. Paracha
DOI: 10.2174/1568010023344643
Published on: 01 March, 2012

A Role for Leptin in the Systemic Inflammatory Response Syndrome (SIRS) and in Immune Response

Volume:1   Issue: 3
Pp: 277-289
W. Waelput, P. Brouckaert, D. Broekaert and J. Tavernier
DOI: 10.2174/1568010023344634
Published on: 01 March, 2012